| Catalog | name | Description | price |
|---|---|---|---|
| R-C-2777 | CY 208-243 CAS:100999-26-6 | CY 208-243 is a drug which acts as a dopamine agonist selective for the D1subtype.Unlike most D1-selective agonists,it shows efficacy in animal models of Parkinson is disease. | price> |
| R-C-2780 | Otenzepad (AF-DX 116) CAS:102394-31-0 | Otenzepad(AF-DX 116)is a selective and competitive M2 muscarinic acetylcholine receptor antagonist,with IC50 values of 640nM and 386nM for rabbit peripheral lung and rat heart,respectively. | price> |
| R-C-2781 | VUF 10460 CAS:1028327-66-3 | VUF10460 is a non-imidazole histamine H4 receptor agonist;binds to rat H4 receptor with a pKi of 7.46. | price> |
| R-C-2792 | TCN 238 CAS:125404-04-8 | TCN238 is an orally bioavailable mGlu4 receptor positive allosteric modulator (PAM)with an EC50 of 1μM. | price> |
| R-C-2797 | L-732,138 CAS:148451-96-1 | L-732138 is a selective,potent and competitive neurokinin-1(NK-1)receptor antagonist with an IC50 of 2.3nM.L-732138 has 200-fold more potent in cloned human NK-1 receptors than cloned rat NK-1 receptors,and has>1000-fold more potent than human NK-2 and NK-3 receptors.L-732138 can reduce hyperalgesia and has antitumor action. | price> |
| R-C-2800 | GR 103691 CAS:162408-66-4 | GR 103691 is a potent,selective dopamine D3 receptor antagonist with a Ki value of 0.4nM.GR 103691 shows more than 100-fold selectivity for human dopamine human(h)D3 over hD4 and hD1 sites. | price> |
| R-C-2804 | Eglumegad (LY354740) CAS:176199-48-7 | Eglumegad(LY354740)is a highly potent and selective group II(mGlu2/3)receptor agonist with IC50s of 5 and 24nM on transfected human mGlu2 and mGlu3 receptors,respectively. | price> |
| R-C-2805 | NKP608 CAS:177707-12-9 | NKP608 is a non-peptidic derivative of 4-aminopiperidine which acts as a selective,specific and potent antagonist at the neurokinin-1(NK-1)receptor both in vitro(IC50=2.6nM)and in vivo. | price> |
| R-C-2806 | Sumanirole maleate CAS:179386-44-8 | Sumanirole maleate(U-95666E;PNU-95666E)is a highly selective D2 receptor full agonist with an ED50 of about 46nM.Sumanirole was developed for the treatment of Parkinson is disease and restless leg syndrome. | price> |
| R-C-2809 | LY 344864 CAS:186544-26-3 | LY344864 is a selective receptor agonist with an affinity of 6 nM(Ki)at the recently cloned 5-HT1F receptor. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


